The Limits of Conventional Treatment and the Need for Integrative Care

Surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy are the important pillars of modern cancer medicine. They bring real help to many patients and have even changed originally grim prognoses. Therefore, any article discussing cancer care should never diminish the importance of standard treatment.

However, as both a researcher and a patient, I am also keenly aware that each of these treatments has its own limitations. Chemotherapy often targets rapidly dividing cells, so it may simultaneously affect bone marrow, the gastrointestinal tract, and hair follicles, causing fatigue, nausea, weakened immunity, and hair loss. Radiotherapy can precisely strike a localized tumor, but may also affect surrounding normal tissue. Targeted therapy is more directional, but not every patient has a suitable target, and cancer cells may still develop drug resistance. Immunotherapy brings new hope, yet it may also trigger immune-related side effects.

These limitations do not mean treatment has failed; rather, they remind us that cancer care needs a more integrated perspective. A patient is not merely a body receiving medication, but a person enduring fatigue, anxiety, pain, waiting, and hope throughout treatment. The medical team needs to address the tumor, while also attending to the patient's nutrition, sleep, physical strength, emotions, family support, and spiritual needs.

In this sense, supportive care is not an optional add-on, but part of the whole treatment journey. Proper nutritional support, symptom management, psychological counseling, exercise rehabilitation, and faith companionship can all help patients retain dignity and strength during treatment.

I have come to believe more and more that cancer treatment is not only about fighting cancer cells, but also about sustaining the patient to keep living out their life. Medicine strives to extend life; faith helps people see eternal hope amid what is finite.